|
|
Article: Prehospital Administration Of Clot-Buster Beneficial For Heart-Attack Patients.
- Article from:
- Drug Week
- Article date:
- October 5, 2001
CopyrightCOPYRIGHT 2001 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
2001 OCT 5 - (NewsRx.com & NewsRx.net) --
A study presented September 2, 2001, at the European Society of Cardiology Congress appears to demonstrate the benefits of the clot-dissolving agent Retavase (reteplase) in the treatment of heart-attack patients.
The study, known as ER-TIMI 19, reported that doctors could accelerate the treatment of heart attack patients by 33 minutes by administering Retavase in the ambulance rather than waiting until the patient reached the hospital.
According to the U.S. National Institutes of Health (NIH), half of the 500,000 deaths from heart attacks each year occur within the first hour of experiencing symptoms ...